NSC |
Compound |
Enrichment |
Correlation |
NSC 135037 |
Jatrophone |
0.0385613993886001 |
-0.28632165 |
NSC 163424 |
4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- |
0.0385613993886001 |
-0.10485592 |
NSC 164991 |
Null |
0.0385613993886001 |
0.28874533 |
NSC 185065 |
Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- |
0.0385613993886001 |
-0.11591306 |
NSC 227279 |
1,4-Naphthalenedione, 5,8-dihydroxy-2,3-bis(hydroxymethyl)- |
0.0385613993886001 |
-0.49577642 |
NSC 303861 |
L-Cysteine analog |
0.0385613993886001 |
-0.34163646 |
NSC 3077 |
s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) |
0.0385613993886001 |
-0.12515211 |
NSC 328410 |
Camptothecin Derivative |
0.0385613993886001 |
-0.045211645 |
NSC 342610 |
Null |
0.0385613993886001 |
-0.097768015 |
NSC 351521 |
Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) |
0.0385613993886001 |
-0.25899073 |